NTBLCP Reiterates TB Test, Treatment Free In Nigeria

NTBLCP Reiterates TB Test, Treatment Free In Nigeria

Dr Chukwuma Anyaike, the Director and National Coordinator, National Tuberculosis, Buruli Ulcer,
and Leprosy Control Programme (NTBLCP), has reiterated that Tuberculosis (TB) test and treatment are free in Nigeria.

He made the emphasis during an interview with the News Agency of Nigeria on Tuesday in Abuja.

He said “anyone coughing for two weeks or more should call 3340 for free TB test.”

Tuberculosis is caused by bacteria that spreads from person to person through microscopic droplets released into the air.

This can happen when someone with active form of tuberculosis coughs, speaks, sneezes, spits, laughs or sings. Although tuberculosis is contagious, it’s not easy to catch.
 
Anyaike, therefore, advised anyone coughing up blood or mucus, chest pain, or pain while breathing, unintentional weight loss, night sweat and chills, among others, not to hesitate to call the number — 3340. 

He called on Nigerians to spread the word and save lives to end TB in the country, cautioning that persons with active TB disease in their lungs could spread it through the air.

He explained that “what I mean by active is that the TB germs are multiplying and spreading in the body. If you’re in close contact with someone who has it, you can be infected.

“That’s why doctors advise those who have active TB disease to stay home and away from other people as much as possible until they’re no longer infectious.

“If you have TB germs in your body but they haven’t become active, you have what doctors call `latent TB.’ You can’t spread the disease to others, but your doctor may still recommend that you take medications to keep the germs from becoming active.”

The NTBLCP national coordinator also said that the U.S. Agency for International Development (USAID), through the STOP TB Partnership, donated new tools for diagnosis and treatment of TB  in the country.

The tools, he added, were recent innovations to support the country in closing the gap in missing tuberculosis and drug-resistant cases and help the country in the treatment of Latent TB infection.

He said “Nigeria is one of the six countries selected to benefit from the ‘introducing New Tools Project (iNTP)’, a global initiative to increase access to new, high-quality diagnostics and treatment for tuberculosis in high TB burden countries.”He added that the 3.3-million-dollar iNTP tools package for Nigeria include 38 WHO-recommended rapid molecular Truenat diagnostic systems adapted for tropical environments and used in lower-level health facilities.

Others were 10 high-tech Ultraportable digital X-ray systems with Computer-Aided Detection software (CAD) Intelligence (AI) for TB screening and TB preventive medicines to protect and prevent the progression of the disease in 21,000 adults and children.

Anyaike said the new tools would be distributed to 18 states in the country, including Lagos, Osun, Oyo,  Kano, Kaduna and Katsina.

Other states are: Bauchi, Nasarawa, Plateau, Benue, Taraba, Anambra, Imo, Delta, Akwa Ibom, Cross River and Rivers.

 

(NAN)

https://nnn.ng/ntblcp-reiterates-test/

Related post

Civil Society Groups Advocate for Comprehensive Health Security Reforms in Nigeria

Civil Society Groups Advocate for Comprehensive Health Security Reforms…

In response to growing concerns about Nigeria’s vulnerability to public health crises, a coalition of civil society organizations recently convened a…
WHO urges collective action against rising diabetes prevalence in Africa

WHO urges collective action against rising diabetes prevalence in…

The World Health Organisation (WHO) Regional Director for Africa,  Dr. Matshidiso Moeti, emphasized the need for a collaborative approach to tackle the…
Tuberculosis resurges as top infectious disease killer

Tuberculosis resurges as top infectious disease killer

The World Health Organization (WHO) today published a new report on tuberculosis revealing that approximately 8.2 million people were newly diagnosed with…

Leave a Reply

Your email address will not be published. Required fields are marked *